Taysha's Chief Sold $1.2: What It Means for Investors
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
This page features valuable insights into the Stock Market, covering topics like tariffs and dividend investing. Stay informed to enhance your investment strategies.
3,082 articlesAn insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
Income-focused investors face a tricky mood: chase reliable payouts or risk capital. Learn about three high-yield div...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
A hypothetical hawkish turn from chair Kevin Warsh sends ripples through markets. This guide explains what it means f...
As the market wrestles with SaaS cycles and AI disruption fears, monday.com stock has seen its share of monday blues....
The space-tech IPO has hit a snag, with shares slipping below the initial price. This guide breaks down what the drop...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Interactive Brokers surged in the first half of 2026 as traders flocked to global markets. This guide breaks down the...
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...